Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

239 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Recruiting

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

NCT07469891

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +13 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • BRCR Global - Coral Springs Coral Springs, Florida, United States
  • START Midwest, LLC Grand Rapids, Michigan, United States
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

NCT05430971

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Hematologic Diseases, +11 more
Locations
  • Sylvester Comprehensive Cancer Center, University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Seattle Children's Cancer and Blood Disorders Center Seattle, Washington, United States
  • Hematology Center named after prof. R. Yeolyan Yerevan, Armenia
View all 22 locations
View Trial Details
Recruiting

A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

NCT06985147

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +7 more
Locations
  • Mayo Clinic in Arizona Phoenix, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Health Los Angeles, California, United States
  • Keck Medicine of USC - Cancer Clinic- Newport Beach Newport Beach, California, United States
View all 15 locations
View Trial Details
Recruiting

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

NCT03779854

Conditions
Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, +54 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View Trial Details
Recruiting

MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

NCT04116502

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Royal United Hospital Bath, United Kingdom
  • Belfast City Hospital Belfast, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
View all 47 locations
View Trial Details
Recruiting

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

NCT06351631

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • University of Michigan ( Site 6000) Ann Arbor, Michigan, United States
  • DUHS Duke Blood Cancer Center ( Site 6005) Durham, North Carolina, United States
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007) Columbus, Ohio, United States
  • UPMC Hillman Cancer Center ( Site 6004) Pittsburgh, Pennsylvania, United States
View all 21 locations
View Trial Details

Related conditions